ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1049

Optical Biomarkers for the Early Diagnosis of Osteoarthritis

Paula Casal Beiroa1,2, Elena F. Burguera2,3,4, Tamara Hermida-Gómez2,3,4, Noa Goyanes5, Natividad Oreiro4,6, Pío González7, Francisco J Blanco8 and Joana Magalhaes2,4,9, 1Unidad de Medicina Regenerativa. Grupo de Investigación en Reumatología (GIR), Instituto de Investigación Biomédica de A Coruña (INIBIC). CHUAC. SERGAS., A Coruña, Spain, 2Centro de Investigaciones Científicas Avanzadas (CICA), Universidad de A Coruña (UDC)., a coruña, Spain, 3Unidad de Medicina Regenerativa, Grupo de Investigación en Reumatología, Agrupación Estratégica CICA-INIBIC, Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas, Universidade de A Coruña (UDC), A Coruña, Spain, 4Centro de Investigación Biomédica en Red (CIBER), madrid, Spain, 5Centro de Investigaciones Científicas Avanzadas (CICA), Universidad de A Coruña (UDC)., A Coruña, Spain, 6Servicio de Reumatología. Instituto de Investigación Biomédica de A Coruña (INIBIC), Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC). As Xubias, 15006. A Coruña. España, A Coruna, Spain, 7Grupo de Nuevos Materiales. Departamento de Física Aplicada. Universidad de Vigo., Vigo, Spain, 8Servicio de Reumatología. Instituto de Investigación Biomédica de A Coruña (INIBIC). Complexo Hospitalario Universitario de A Coruña (CHUAC). Sergas. Universidade de A Coruña (UDC), A Coruña, Spain, 9Unidad de Medicina Regenerativa. Grupo de Investigación en Reumatología (GIR), Instituto de Investigación Biomédica de A Coruña (INIBIC). CHUAC. SERGAS., a coruña, Spain

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Biomarkers, cartilage, diagnosis, human resources and osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 22, 2018

Title: Osteoarthritis and Joint Biology – Basic Science Poster I

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM


Background/Purpose: Osteoarthritis (OA) is a rheumatic disease characterized by articular cartilage degradation. On its early stages, OA is asymptomatic and its current gold-standard diagnosis (X-Rays), focused on changes on the adjacent tissue – bone – presents a limitation to the early diagnosis of this disease. Raman spectroscopy (RS) has been recently described as a non-invasive tool to detect molecular changes in biological tissues, producing a unique fingerprint. For this reason, its application for the diagnosis of different diseases offers high potential. Beyond its clinical application, RS offers value as a molecular quantification technique for tissue engineered cartilage characterization. The aim of this work was to evaluate the potential of RS for the early diagnosis of OA.

Methods: Human hip cartilage explants (n=14), from healthy (H) and OA donors, with Kellgren-Lawrence (K-L) radiological grades from 0 to IV, were obtained after informed consent. Raman analysis was performed on fresh tissue, using a Bruker RFS100 Spectrometer with a Nd:YaG laser (ʎ=1064). Main peaks were assigned according to literature3, following their area’s measurement after a normalization process. One-way ANOVA statistical analysis was performed and differences considered significant for p<0.05. We further analyzed correlations (Pearson’s coefficient) between peaks and K-L grade.

Results: RS cartilage spectra (Fig.1A) revealed the following assignments: 1245-1270cm-1 amide III doublet (random coil and α-helix collagen), 1063cm-1 (sulfated glycosaminoglycans, GAGs), 1377cm-1 (proteoglycans, PG), 1450cm-1 (nonspecific signal of lipids and proteins) and 1668cm-1 (carbonyl group in proteins). For higher K-L grades, a peak appeared at 960cm-1 (apatite phosphate), related to tissue mineralization. After quantitative analysis (Fig.1B) we observed the main molecular changes: GAGs and PG peaks showed a significant decrease with OA severity (p<0.01), supported by high correlation coefficients (R2=0.7361 and R2=0.7999, respectively), related to GAGs’ degradation; an increase in 1245/1270 ratio (defective/functional collagen) could reveal collagen arrangement loss, although there was a low correlation vs K-L (R2=0.3764); an indirect lipid index (IL), calculated as A1450/A1668, showed an increase of lipids in OA tissues.

Conclusion: RS analysis revealed a hip cartilage molecular fingerprint. Variations found between H and OA tissue are representative of the molecular changes during OA progression. A set of parameters is suggested as an optical biomarker panel: defective/functional collagen (1245-1270cm-1), GAGs (1063cm-1), PG (1377cm-1) and IL (1450/1668).



 


Disclosure: P. Casal Beiroa, None; E. F. Burguera, None; T. Hermida-Gómez, None; N. Goyanes, None; N. Oreiro, None; P. González, None; F. J. Blanco, None; J. Magalhaes, None.

To cite this abstract in AMA style:

Casal Beiroa P, Burguera EF, Hermida-Gómez T, Goyanes N, Oreiro N, González P, Blanco FJ, Magalhaes J. Optical Biomarkers for the Early Diagnosis of Osteoarthritis [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/optical-biomarkers-for-the-early-diagnosis-of-osteoarthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/optical-biomarkers-for-the-early-diagnosis-of-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology